This analytical method for easier determination of codeine in human plasma is based on "high-performance" liquid chromatography for separation and the natural fluorescence of codeine for detection. Codeine is extracted from alkalinized plasma with a mixture of hexane and dichloromethane, and the extract is further purified and chromatographed. The method can be used for routine assay of codeine at the concentrations of 10 rg/L or greater in human plasma. As little as 4 JLg/L can be detected. Coefficients of variation for the assay of codeine in the concentration range of 10 to 100 tg/L were 2.2-7.4% (n = 6). We used this method to establish a concentration/ time profile for plasma from a human volunteer after a 60-mg oral dose of codeine sulfate.
Liquid Chromatography of Codeine in Plasma with Fluorescence Detection
Irene W. Tslna, Marian Fass, Jennifer A. Debban, and Shaikh B. Matin This analytical method for easier determination of codeine in human plasma is based on "high-performance" liquid chromatography for separation and the natural fluorescence of codeine for detection. Codeine is extracted from alkalinized plasma with a mixture of hexane and dichloromethane, and the extract is further purified and chromatographed. The method can be used for routine assay of codeine at the concentrations of 10 rg/L or greater in human plasma. As little as 4 JLg/L can be detected. Coefficients of variation for the assay of codeine in the concentration range of 10 to 100 tg/L were 2.2-7.4% (n = 6). We used this method to establish a concentration/ time profile for plasma from a human volunteer after a 60-mg oral dose of codeine sulfate. Thin-layer chromatography combined with nitration of in situ codeine has been used for the quantitation of nanogram amounts of codeine in plasma (5) . This method, however, is tedious.
A method based on gas chromatography/mass spectroscopy has also been described (6) , but the expensive and sophisticated instrumentation required is not found in many clinical laboratories, and the technique is not suitable for analysis of a large number of samples.
More recently, a sensitive radioimmunoassay procedure has been developed for the assay of codeine in plasma (7, 8) .
Here we describe a sensitive and rapid assay for codeine in human plasma by "high-performance" liquid chromatography (HPLC), with fluorescence detection. to 13.7 X 10 Pa). The recorder was used at a chart speed of 5 mm/mm. fluoresce under the described assay conditions. As a result, by using fluorescence detection, we were able to minimize sample purification before HPLC analysis. Tritiated codeine was used to establish the extraction efficiency and total recovery for this procedure. The radiochemical purity of [3HJ codeine was first established by thinlayer chromatography.
Materials and Methods

Chemicals
Results and Discussion
The Rf of codeine in a solvent system of acetone/dichloromethane/methanollammonium hydroxide (30/10/5/1 by vol) on a silica gel plate was 0.31.
[3H]Codeine was added to drug-free plasma and the radioactivity was monitored through each step of the procedure. The extraction efficiency of codeine from alkalinized plasma by the hexane/ dichioromethane extraction solvent was 80%. The total recovery of codeine subjected to the entire extraction and clean-up procedure, up to and just before HPLC, was 75%.
Adding a small amount of phosphoric acid to the mobile phase results in the formation of an ion-pair with codeine. This improved peak shapes and allowed the detection of codeine at nanogram quantities.
To obtain better reproducibility with this procedure, we included a structural analog of codeine, N-isopropylcodeine, as an internal standard.
Codeine and the internal standard were extracted similarly and resolved well under the described chromatographic conditions. To study the precision of the method, we fortified drug-free plasma with codeine at concentrations of 10,25,50,75, or 100 1ug/L and assayed six sets of fortified samples on six separate days. Between-assay coefficients of variation (CV) at each concentration are shown in Table 1 . Calibration curves obtained by analyzing plasma samples fortified with codeine in the concentration range of 10 to 100 tg/L were subjected to regression analysis ( Table 2 ). The statistics of the data from six calibration curves indicated the linearity and reproducibility of the assay in this concentration range. The lower limit of quantitation for this method was set at 10og/L. At this concentration the CV for the assay of codeine in plasma was 7.4%, and the signal-to-noise ratio for the codeine peak was approximately 6. From this we estimated that a signal-to-noise ratio of 2 would be obtained for a sample containing 4 ig of codeine per liter, and this concentration was set as the minimum detectable limit of the method. To investigate the possibility that drugs administered with codeine or metabolic products of codeine might interfere with the measurement of codeine, we injected selected compounds onto the HPLC under the described conditions and determined the retention times for the compounds (Table 3) . Of all the compounds investigated, only N-norcodeine (retention conditions. However, only trace amounts (<10 g/L) of N-norcodeine have been reported (3) to be present in plasma of some subjects who had been dosed with codeine. This trace amount, which was present in plasma only at the peak codeine concentration time (3), was not considered to be significant enough to affect the assay of codeine in plasma. Metabolically generated morphine
Internal
was not detected by this method. Because of the relatively low polarity of the extraction solvent, morphine was not extracted with codeine from plasma. We therefore cannot use this method for the simultaneous detection of morphine and codeine. All of the chromatograms from plasma extracts had a negative baseline deflection between 8 and 9 mm after injection.
We later confirmed that this negative baseline deflection was due to the presence of caffeine (5 mg/L or more) in plasma from subjects who had consumed caffeine-containing beverages. Therefore, it is critical that the HPLC columns and the mobile phase used can separate caffeine (retention time, 9 mm) from internal standard (retention time, 7 mm). To demonstrate the applicability of the developed method, a human volunteer ingested 60 mg of codeine sulfate. Codeine concentrations in plasma of this subject were similar to previously reported values (5): at 20 and 40 mm and 1,2,4,8, and 10 h after the dose, the codeine concentrations were 11, 90, 101, 84, 43, 17, and 13 g/L, respectively.
The peak concentration in plasma occurred I h after the dose and the rate of decreaseof drug concentration indicated a half-life of 2.65 h. Between 10 and 24 h after the dose, codeine concentration in the plasma decreased to less than the limit of quantitation for the method (10 igfL).
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